Hot News

《輪市總結》友邦業績後升逾3%,工行建行相關窩輪成交持續上升 @ 2012-02-24T18: Back Hot News
Keyword:成交 窩輪
Concept:工行16619 , 恆指相關窩輪成交
港股隨外圍造好,恆指收報21,491點,升214點,升幅約1%,匯控(00005)及中人壽(02628)推升大市,分別為恆指貢獻53點及20點,大市成交增加至662.9億元,單日增加5.5%,窩輪成交則減至101.64億元,單日減少3.2%,窩輪占大市成交約15.3%。中人壽表現突出,正股及窩輪成交活躍。
恆指窩輪成交今日錄得45億元,單日增加2%,占窩輪市場成交的49%。恆指成分股當中,友邦(01299-HK)表現突出,一度升超過3%,並企穩26元以上,收報26.25元,升0.35元,升幅約1.4%,相關窩輪成交增加10%至7,000萬元。
希債援助方案有望於下周拍板,令歐債問題現轉機,加上美國數據理想,刺激周四美股高收。港股昨日跟隨外圍造好,恆指高開逾200點,收市報21,491點,穩守250天牛熊分界線之余,亦創半年高位,成交總額達665.85億元。全日窩輪及牛熊證成交額分別為102.01億及83.07億元,占主板成交比重15.4%及12.5%。總結一周,恆指累升707點或3.4%,更錄得連續七周上升的「七連升」佳績,累升共3,057點,升幅近17%。
恆指是今日最活躍的窩輪相關資產,成交錄得45﹒7億元,單日微增2%,個股窩輪成交
港股今日大致缺乏方向,恆指全日高、低位分別是21,468點和21,292點,收報21,406點,升25點或0.12%。大市成交維持在約600億元,單日增加1.9%,窩輪成交同步回升,錄得94.14億元,單日上升6.1%,窩輪占大市成交約15.3%。工行(01398-HK)和建行(00939-HK)相關窩輪成交持續上升,反觀業績後大升的友邦(01299-HK),相關窩輪成交只較昨日上升9%。
內地股市午後升幅擴大,上證綜合指數全日升1﹒96%至2312點收市,帶動港股升勢。技術上,恆指正進一步逼近250天平均線的21092點,同時其14天RSI已升見71的超買區域。恆指相關窩輪成交保持活躍,占窩輪市場49%。恆指認沽證15844成交活躍,其行使價18800點,今年6月到期,換股比率8000,引伸波幅約31﹒7%此外,安碩A50中國(02823)收報11﹒46元,升3﹒8%,亦是今日第五大成交港股。A50相關窩輪占窩輪市場約2%成交,是10大活躍窩輪相關資產之一。A50認購證13678成交活躍,收報0﹒082元,單日升24﹒6%,其行使價13﹒3元,今年10月到期,實際槓桿約6﹒1倍,引伸波幅約31﹒3%。
恆指是今日最活躍窩輪相關資產,相關窩輪錄得近48億元成交,占窩輪市場44%。恆指
恆指窩輪成交與上日相若,錄得51﹒6億元,仍然是最活躍的窩輪相關資產。值得留意的是,多只藍籌股今日表現突出,相關窩輪成交明顯增加,如中移動(00941)收市升穿81元水平,報81﹒25元,升1﹒8%,相關窩輪成交較上日急增95%至約9﹒5億元,占窩輪市場成交的9%,是第二大活躍的窩輪相關資產。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.